Synonyms: mPEG-PTH (1-34) | TransCon PTH | Yorvipath®
palopegteriparatide is an approved drug (EMA (2023), FDA (2024))
Compound class:
Peptide
Comment: Palopegteriparatide is a synthetic parathyroid hormone mimetic prodrug. Structurally it is an N-terminally PEGylated fragment of amino acids 1-34 of the mature human peptide (84 aa) [1]. Palopegteriparatide is inactive at the PTH receptor until the peptide-PEG linker is cleaved, releasing the active PTH(1-34) peptide.
|
For advanced searching click here to open chemical structure editor